Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Rifaquat Musaffa Rahman, M.D.

Concepts (122)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms19202285212.110 Why?
Glioblastoma16202232251.830 Why?
Controlled Clinical Trials as Topic120211910.830 Why?
Glioma3202231220.750 Why?
Cranial Irradiation220204220.710 Why?
Central Nervous System Neoplasms220228320.630 Why?
Antineoplastic Agents, Alkylating120206270.590 Why?
Clinical Trials, Phase III as Topic120197930.570 Why?
Patient Care120215780.560 Why?
Angiogenesis Inhibitors5201720500.530 Why?
Neurology120217190.500 Why?
Meningioma1202111550.490 Why?
Meningeal Neoplasms1202111760.480 Why?
Rectal Neoplasms1202110620.470 Why?
Radiation Injuries1202012230.470 Why?
Research Design4202257360.450 Why?
Proportional Hazards Models42021122670.420 Why?
Medical Oncology2202119500.410 Why?
Neoplasm Recurrence, Local5201785890.380 Why?
Randomized Controlled Trials as Topic4202192430.370 Why?
Information Dissemination3202110650.330 Why?
Salvage Therapy1201412810.320 Why?
Immunotherapy3202239100.310 Why?
Antineoplastic Agents32021135690.240 Why?
Models, Biological1202097750.240 Why?
Radiosurgery2202212910.230 Why?
Pandemics1202162000.220 Why?
Medical Futility120221210.210 Why?
Survival Analysis62021104740.210 Why?
Melanoma1201853420.190 Why?
Drug Resistance, Neoplasm1201451440.180 Why?
Prostatic Neoplasms12021105100.170 Why?
Drugs, Investigational120212370.170 Why?
Standard of Care120213850.170 Why?
Combined Modality Therapy3202088280.170 Why?
Humans3320226858840.160 Why?
SEER Program1202215420.160 Why?
Hospitalization1201593360.150 Why?
Retrospective Studies122022680430.150 Why?
Comparative Effectiveness Research120216580.140 Why?
Gene Dosage1202012530.140 Why?
Tumor Burden3201818850.140 Why?
Lomustine12014640.140 Why?
Neoplasms22021196220.140 Why?
Carmustine120141440.140 Why?
Breast Neoplasms12021191590.130 Why?
Kaplan-Meier Estimate3202167390.130 Why?
Disease Progression52018130160.130 Why?
Infection Control120219360.120 Why?
Treatment Outcome82021602000.120 Why?
Antineoplastic Combined Chemotherapy Protocols12014110320.120 Why?
Magnetic Resonance Imaging72022332490.120 Why?
Carcinoma, Non-Small-Cell Lung2202146780.120 Why?
Astrocytoma120157730.110 Why?
Sarcoma1202218040.100 Why?
Aged, 80 and over62020577780.100 Why?
Aged920201594750.100 Why?
Middle Aged1220202117470.090 Why?
Patient Selection2202142430.090 Why?
Male1520213452990.090 Why?
Prognosis52022284700.090 Why?
Young Adult82018546460.090 Why?
Clinical Trials as Topic3202279410.090 Why?
Patient Participation1201814110.090 Why?
Risk1202197170.090 Why?
Female1420213687810.090 Why?
Adult1120222078470.090 Why?
Radiology1202118420.080 Why?
Decision Making2202137670.080 Why?
Computational Biology1202035020.080 Why?
Lung Neoplasms22021120580.080 Why?
Molecular Targeted Therapy1201828250.080 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors1202130230.080 Why?
Diffusion Magnetic Resonance Imaging2201625730.070 Why?
Survival Rate32017131870.070 Why?
Cues120108280.070 Why?
Neoplasm Proteins1201838390.070 Why?
Head and Neck Neoplasms1201826150.070 Why?
Algorithms22022133430.060 Why?
Photic Stimulation1201020150.060 Why?
Reaction Time1201020990.060 Why?
Carcinoma, Squamous Cell1201838930.060 Why?
Mutation32022285120.060 Why?
Incidence22020201490.050 Why?
Students1201014590.050 Why?
Memory1201020960.050 Why?
Ribonuclease III120222590.050 Why?
DEAD-box RNA Helicases120223380.050 Why?
Disease-Free Survival3201670240.050 Why?
Neoplasm Staging12014110240.050 Why?
Pathology, Molecular120223260.050 Why?
Risk Assessment12021231520.050 Why?
Necrosis1202016110.040 Why?
Probability1202224720.040 Why?
Follow-Up Studies22017388340.040 Why?
United States12022654030.030 Why?
Substance-Related Disorders1201041010.030 Why?
Retreatment120156170.030 Why?
Phantoms, Imaging1202223280.030 Why?
Clinical Trials, Phase II as Topic120156030.030 Why?
Immune Tolerance1202222970.030 Why?
Dacarbazine120155800.030 Why?
Radiation Dosage1202120260.030 Why?
Area Under Curve1201516790.030 Why?
Echo-Planar Imaging120146600.020 Why?
Lymphatic Metastasis1201729360.020 Why?
High-Throughput Nucleotide Sequencing1202235570.020 Why?
Observer Variation1201526640.020 Why?
Risk Factors12015686780.020 Why?
ROC Curve1201534690.020 Why?
Marijuana Smoking120102470.020 Why?
Neoplasm Metastasis1201851480.020 Why?
Databases, Factual1202175650.020 Why?
Prospective Studies22021493760.020 Why?
Contrast Media1201751640.020 Why?
Image Interpretation, Computer-Assisted1201633820.010 Why?
Image Processing, Computer-Assisted1201788470.010 Why?
Time Factors12021408170.010 Why?
Predictive Value of Tests12014150940.010 Why?
Alcohol Drinking1201037830.010 Why?
Brain12022243370.010 Why?
Child12022716170.010 Why?
Rahman's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (122)
Co-Authors (64)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.